Related Experiment Video
Updated: Jun 3, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Testicular function and fertility preservation in male cancer patients
Kirsi Jahnukainen1, Jens Ehmcke, Mi Hou
1Division of Hematology-Oncology and Stem Cell Transplantation, Hospital for Children and Adolescents, University of Helsinki, FIN-00029 Helsinki, Finland. kirsi.jahnukainen@ki.se
Abstract:
The testis has been shown to be highly susceptible to the toxic effects of cancer therapy at all stages of life. Young cancer survivors are approximately half as likely as their siblings to sire a pregnancy. Radiation therapy to the testes and high cumulative dose of alkylating agents are the major factors decreasing the probability of fertility. This review aims to present an overview of the current state of knowledge in mechanisms how human spermatogonia proliferate and differentiate and how cancer therapy affects germ cells, what are the options for fertility preservation and what are the clinical risks and limitations related to such procedures. This area of research is discussed in the context of the potential future options that may become available for preserving fertility in male cancer patients.
Insights
Cancer therapies like radiation and chemotherapy significantly impair male fertility by damaging sperm stem cells. Fertility preservation options are crucial for young cancer survivors to maintain reproductive potential.
Area of Science:
- Reproductive biology
- Oncology
- Medical science
Background:
- Testicular toxicity from cancer therapy impacts fertility across all ages.
- Young cancer survivors have a reduced likelihood of fathering a pregnancy compared to siblings.
- Radiation therapy and high-dose alkylating agents are primary contributors to male infertility post-cancer treatment.
Purpose of the Study:
- To review mechanisms of human spermatogonia proliferation and differentiation.
- To examine the effects of cancer therapy on male germ cells.
- To discuss current and future fertility preservation strategies for male cancer patients.
Main Methods:
- Literature review of scientific articles and clinical studies.
- Analysis of data on male fertility post-cancer treatment.
- Synthesis of information on spermatogenesis and gonadotoxicity.
Main Results:
- Cancer therapies, particularly radiation and alkylating agents, severely affect spermatogonia, leading to reduced fertility.
- Existing fertility preservation methods have associated risks and limitations.
- Understanding germ cell biology is key to improving preservation techniques.
Conclusions:
- Male fertility is highly vulnerable to cancer treatments.
- Current fertility preservation options require careful consideration of risks and benefits.
- Future research holds promise for novel fertility preservation strategies in male cancer survivors.
More Related Videos
Related Concept Videos
Infertility in Males
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Spermatogenesis
Testosterone: Functions and Regulation
Testes: Histology
The spermatogenic cells, responsible for producing sperm, are...
Testes: Gross Anatomy
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...
